Adage Capital Partners Gp, L.L.C. Royalty Pharma PLC Transaction History

Adage Capital Partners Gp, L.L.C.

$54.9 Billion
Q4 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 16,968,321 shares of RPRX stock, worth $549 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

16,968,321

Previous 11,899,194 42.6%

Holding current value

$549 Million

Previous $337 Million 28.59%

% of portfolio

0.79%

Previous 0.62%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$24.28 - $28.39 $123 Million - $144 Million	5,069,127 Added 42.6%	16,968,321 $433 Million
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $24.8 Million - $28.3 Million	967,263 Added 8.85%	11,899,194 $337 Million
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $3.02 Million - $3.44 Million	115,000 Added 1.06%	10,931,931 $288 Million
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $2.2 Million - $2.51 Million	-80,000 Reduced 0.73%	10,816,931 $329 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $27.7 Million - $30.9 Million	1,056,931 Added 10.74%	10,896,931 $306 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $31.2 Million - $37.3 Million	1,190,000 Added 13.76%	9,840,000 $267 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $41.6 Million - $51.4 Million	1,405,133 Added 19.39%	8,650,000 $266 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $8.02 Million - $9.65 Million	244,867 Added 3.5%	7,244,867 $261 Million
Q4 2022 Feb 14, 2023	SELL	$39.17 - $44.04 $45.6 Million - $51.3 Million	-1,165,000 Reduced 14.27%	7,000,000 $277 Million
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $341 Million - $381 Million	-8,542,815 Reduced 51.13%	8,165,000 $328 Million
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $305 Million - $360 Million	-8,134,900 Reduced 32.75%	16,707,815 $702 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $5.1 Million - $6.16 Million	144,900 Added 0.59%	24,842,715 $990 Million
Q3 2021 Nov 15, 2021	BUY	$36.14 - $42.24 $71.4 Million - $83.5 Million	1,976,000 Added 8.7%	24,697,815 $893 Million
Q2 2021 Aug 16, 2021	SELL	$39.85 - $46.63 $78.3 Million - $91.7 Million	-1,965,941 Reduced 7.96%	22,721,815 $931 Million
Q1 2021 May 17, 2021	SELL	$42.34 - $52.82 $594 Million - $741 Million	-14,026,524 Reduced 36.23%	24,687,756 $1.08 Billion
Q4 2020 Feb 16, 2021	SELL	$36.12 - $50.05 $264 Million - $365 Million	-7,301,050 Reduced 15.87%	38,714,280 $1.94 Billion
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $2.05 Billion - $2.4 Billion	46,015,330 New	46,015,330 $2.23 Billion

Others Institutions Holding RPRX

# of Institutions

429

Shares Held

291M

Call Options Held

557K

Put Options Held

80K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Royalty Pharma PLC Transaction History